rs200153557
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_003803.4(MYOM1):āc.1813C>Gā(p.Leu605Val) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003803.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOM1 | NM_003803.4 | c.1813C>G | p.Leu605Val | missense_variant | 12/38 | ENST00000356443.9 | NP_003794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM1 | ENST00000356443.9 | c.1813C>G | p.Leu605Val | missense_variant | 12/38 | 1 | NM_003803.4 | ENSP00000348821 | P2 | |
MYOM1 | ENST00000261606.11 | c.1813C>G | p.Leu605Val | missense_variant | 12/37 | 1 | ENSP00000261606 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000670 AC: 102AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000213 AC: 53AN: 249100Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135126
GnomAD4 exome AF: 0.0000725 AC: 106AN: 1461504Hom.: 0 Cov.: 30 AF XY: 0.0000633 AC XY: 46AN XY: 727030
GnomAD4 genome AF: 0.000670 AC: 102AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The p.L605V variant (also known as c.1813C>G), located in coding exon 11 of the MYOM1 gene, results from a C to G substitution at nucleotide position 1813. The leucine at codon 605 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at